BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported third-quarter net income of $26.6 million, after reporting a loss in the same period a year earlier.
The Baudette, Minnesota-based company said it had net income of $1.13 per share. Earnings, adjusted for one-time gains and costs, were $2.04 per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.74 per share.
The drugmaker posted revenue of $227.8 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $211.3 million.
ANI expects full-year revenue in the range of $854 million to $873 million.
ANI shares have risen 63% since the beginning of the year. The stock has risen 55% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
